Researchers hope models could help to determine the rate-limiting processes for a range of other tauopathies and aggregation-related neurodegenerative diseases.
For the first time, researchers have used human data to quantify the speed of different processes that lead to Alzheimer's disease and found that it develops in a very different way than previously thought.